Westend Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.4K Hold
266
– – 0.01% 125
2026
Q1
$22.7K Hold
266
– – 0.01% 119
2025
Q4
$21K Hold
266
– – 0.01% 120
2025
Q3
$21.3K Hold
266
– – 0.01% 102
2025
Q2
$24.2K Hold
266
– – 0.01% 96
2025
Q1
$24.9K Buy
266
+140
+111% +$12.5K 0.01% 90
2024
Q4
$11.5K Hold
126
– – ﹤0.01% 111
2024
Q3
$13.1K Hold
126
– – ﹤0.01% 114
2024
Q2
$12K Buy
126
+51
+68% +$4.71K ﹤0.01% 99
2024
Q1
$6.75K Buy
+75
New +$6.36K ﹤0.01% 144

Other funds holding CL

Westend Capital Management's CL Position: Q2 2026 in Review

Westend Capital Management held its Colgate-Palmolive (CL) position steady in Q2 2026 at 266 shares worth $24.4K. The position accounts for 0.01% of the portfolio, ranked #125.

Westend Capital Management first reported a position in CL in Q1 2024 and has held it in 10 quarters since. The position peaked at $24.9K in Q1 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Westend Capital Management held 266 shares of Colgate-Palmolive worth $24.4K as of Q2 2026.
  • Westend Capital Management left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.01% of Westend Capital Management's portfolio in Q2 2026, its #125 holding.
  • Westend Capital Management first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • Westend Capital Management's Colgate-Palmolive position peaked at $24.9K in Q1 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Westend Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.